Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Mineshita, S. Matsuoka, T. Miyazawa (Kawasaki, Japan). The effects of bronchodilators on regional lung sound distribution in patients with COPD. Eur Respir J 2013; 42: Suppl. 57, 2505

Member's Comments

No comment yet.

Related content which might interest you: Bronchodilator response of advanced lung function parameters depending on COPD severity Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Comparison of protective effect of bronchodilators in COPD Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 Effect of dual bronchodilation with indacaterol/glycopirronium on small airways resistance in patients with stable COPD Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016 Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 COPD, obesity and non-invasive ventilation Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes Year: 2013 The correlation between lung sound distribution and pulmonary function in COPD patients is influenced by emphysematous lesions Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Volumetric capnography in distinct phenotypes of COPD patients Source: International Congress 2016 – Lung function and imaging: new findings and new approaches Year: 2016 Estimated postoperative pulmonary function and 6 months recovery for lobectomized lung cancer patients with and without COPD Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016 Effect of tiotropium compared to salmetrol on dynamic hyperinflation in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Body-plethysmographic measurements of bronchodilator response in stable COPD Source: International Congress 2014 – Airways: reversibility and responsiveness Year: 2014 Patients with severe COPD show significant improvements in dyspnea and lung function with once-daily QVA149: The BLAZE study Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Effect of breathing parameters on lung dose in case of two combination drugs used in asthma and COPD therapy Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Effect of aclidinium bromide on static lung function and hyperinflation in patients with moderate to severe COPD Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD Year: 2013 LATE-BREAKING ABSTRACT: The effect of beta2-agonist on lung clearance index in COPD patients Source: International Congress 2015 – Lung function: new findings and approaches Year: 2015 Differential response between cycling and walking test following pulmonary rehabilitation in patients with COPD depends on degree of lung hyperinflation Source: International Congress 2015 – Best abstracts on pulmonary rehabilitation in chronic lung diseases Year: 2015 Prevalence of small airway dysfunction among GOLD stages in COPD patients Source: International Congress 2016 – Functional assessment of the airways Year: 2016 Prediction of exercise capacity using impulse oscillation system in patients with COPD Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Scintigraphic parameters in COPD patients Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked Year: 2013 The predictors for COPD exacerbations using remote patient monitoring Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Glycopyrronium significantly improves lung function, dyspnea and health status in COPD patients in all GOLD groups Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015